PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which drug helps men with advanced prostate cancer live longer?
Disease control CompletedThis study looked at real-world medical records to compare two common drugs for advanced prostate cancer that has spread and stopped responding to standard hormone therapy. Researchers analyzed data from over 2,700 men who started treatment with either enzalutamide or abiraterone…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Targeted immunotherapy shows promise for tough prostate cancers
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs could help control advanced prostate cancer that had stopped responding to standard hormone treatments. The trial specifically enrolled 69 men whose cancers had certain genetic features that might make them more r…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC